Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Site News

Added 10 hours ago Drug news

Global survey investigating perceptions of Alzheimer's disease-Novartis + Amgen + Banner.

Novartis, Amgen and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), announced results from the largest global...

Added 10 hours ago Drug news

European approval for Ozalin as premedication before procedures in children.- Primex Pharma

Primex Pharmaceuticals AG announces it has received marketing authorization (MA) in the EU via the decentralised procedure for Ozalin (ADV...

Added 10 hours ago Drug news

Phase III CONVERT study of amikacin liposome suspension in nontuberculous mycobacterial lung disease published in AJRCCM.- Insmed.

Insmed Incorporated announced that data from the pivotal Phase III CONVERT study evaluating the safety and efficacy of ALIS (amikacin...

Added 10 hours ago Drug news

Positive Phase III data for Yupelri to treat COPD exacerbations.- Theravance + Mylan

Theravance Biopharma, Inc. and Mylan N.V. announced that positive new data from the companies' Phase III clinical program for Yupelri...

Added 10 hours ago Drug news

FDA approves Ajovy for preventative treatment of migraine.- Teva

Teva Pharmaceutical Industries Ltd. announced that the FDA has approved Ajovy (fremanezumab-vfrm) injection for the preventive treatment of migraine in...

Added 10 hours ago Drug news

NICE recommends use of Tafinlar + Mekinist in BRAF V600 mutation-positive melanoma.- Novartis.

The National Institute for Health and Care Excellence (NICE) has announced that it is supporting NHS funding for the oral...

Added 10 hours ago Drug news

Successful KRONOS Phase III trial of triple therapy (PT 010) for COPD. AstraZeneca

AstraZeneca has announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple...

Added 9 hours ago Congress news

Babies exposed to higher levels of organochlorine compounds in the womb go on to have worse lung function in childhood

Dangerous chemicals present in the environment still causing long-term health problems.

Added 1 day ago Drug news

INPULSIS-ON trial data on Ofev in IPF published in The Lancet Respir Med.- Boehringer.

Results from INPULSIS-ON, published in Lancet Respiratory Medicine, provide insights into the long-term safety, efficacy and tolerability of Ofev (nintedanib),...

Search all news articles